Biomarker development to integrate immune effector and suppressor responses in cancer

Date 08 December 2017
Event ESMO Immuno-Oncology Congress 2017
Session Innovative biomarkers and immune profiling
Topics Bioethics, Legal, and Economic Issues
Presenter Lisa Butterfield
Authors L. Butterfield
  • Medicine, University of Pittsburgh Cancer Institute, 15232 - Pittsburgh/US